Cited by 352Adrenal and Paraganglionic TumorsPhosphodiesterase function and regulationPituitary Gland Disorders and Treatments

A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia

Horvath, Anelia, Boikos, Sosipatros, Giatzakis, Christoforos, Robinson-White, Audrey, Groussin, Lionel, Griffin, Kurt J, Stein, Erica, Levine, Elizabeth +15 more·2006·Nature Genetics

Abstract

Phosphodiesterases (PDEs) regulate cyclic nucleotide levels. Increased cyclic AMP (cAMP) signaling has been associated with PRKAR1A or GNAS mutations and leads to adrenocortical tumors and Cushing syndrome. We investigated the genetic source of Cushing syndrome in individuals with adrenocortical hyperplasia that was not caused by known defects. We performed genome-wide SNP genotyping, including the adrenocortical tumor DNA. The region with the highest probability to harbor a susceptibility gene by loss of heterozygosity (LOH) and other analyses was 2q31-2q35. We identified mutations disrupting the expression of the PDE11A isoform-4 gene (PDE11A) in three kindreds. Tumor tissues showed 2q31-2q35 LOH, decreased protein expression and high cyclic nucleotide levels and cAMP-responsive element binding protein (CREB) phosphorylation. PDE11A codes for a dual-specificity PDE that is expressed in adrenal cortex and is partially inhibited by tadalafil and other PDE inhibitors; its germline inactivation is associated with adrenocortical hyperplasia, suggesting another means by which dysregulation of cAMP signaling causes endocrine tumors.

Integrity signals

Registry

Crossref · 10.1038/ng1809

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mutations in PDE11A and PDE8B are the most commonly reported phosphodiesterase mutations in cortisol-producing adrenocortical adenomas.

    “Mutations in PDE11A and PDE8B genes are the most commonly reported (149,150).”

    From Adrenal incidentaloma (2020) · cites this paper as [149]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., Keil, M., Heyerdahl, S., Matyakhina, L., Libè, R., Fratticci, A., Kirschner, L. S., Cramer, K., Gaillard, R. C., Bertagna, X., Carney, J. A., Bertherat, J., Bossis, I., & Stratakis, C. A.
Affiliations
  • National Institutes of Health (US)
  • Centre National de la Recherche Scientifique (FR)
  • The Ohio State University (US)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • Mayo Clinic (US)
Corresponding author
Stratakis, Constantine A
Venue
Nature Genetics
Published
2006-06-11
Volume
38
Issue
7
Pages
794-800
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2009917029
Cited by
352
References
30
Citations by year
2026: 12 · 2025: 8 · 2024: 14 · 2023: 15 · 2022: 15 · 2021: 12 · 2020: 19 · 2019: 8 · 2018: 16 · 2017: 17 · 2016: 18 · 2015: 21 · 2014: 26 · 2013: 12 · 2012: 18
FWCI
22.71
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
PDE11A, adrenocortical hyperplasia, Cushing's syndrome, cAMP signaling, loss of heterozygosity, CREB phosphorylation, germline mutations, adrenocortical tumors, phosphodiesterase inhibitors, tadalafil, endocrine tumors, cyclic nucleotides
MeSH terms
Adrenal Glands, Adult, Child, Chromosomes, Human, Pair 2, Cushing Syndrome, Female, Humans, Hyperplasia, Male, Mutation, Phosphoric Diester Hydrolases, 3',5'-Cyclic-GMP Phosphodiesterases, Loss of Heterozygosity, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review